follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      Homezz - QuoteMedia Topics And SectorsNASDAQ

      NASDAQ

      Axcelis Technologies, Inc.
      Computer Hardware

      Axcelis Technologies, Inc. Overbought in Morning Session

      Oct 25 Jen Jiang
      As of morning trading, Axcelis Technologies, Inc. (NASDAQ:$ACLS)’s current distance from 20-Day Simple Moving Average is 17.05%, standing 36.66% away from 50-Day Simple Moving Average while trading up 62.06% from the 200-Day Simple Moving Average. ... [Read]
      Health

      Price Target Update on Spectrum Pharmaceuticals, Inc.

      Oct 24 Jen Jiang
      Spectrum Pharmaceuticals, Inc. (NASDAQ:$SPPI) plundered a cool -2.43% with the closing price of $18.90 as of morning trading. The overall volume in the last trading session was 2.7 million shares. ROI is a form of ... [Read]
      SunPower Corporation
      Energy

      SunPower Corporation Registers a 2.84% Price Change After Morning Session

      Oct 24 Jen Jiang
      As of morning trading, SunPower Corporation (NASDAQ:$SPWR) stock saw a move of 2.84% with the closing price of $6.87. During the past week, the company saw a total shift of 1.93%. Over the last three ... [Read]
      NASDAQ

      Head-to-Head: Axcelis Technologies VS Xcerra Corporation

      Oct 24 Dylan Bernhardt
      When it comes to small-cap computer technology companies, Xcerra Corporation (NASDAQ:$XCRA) and Axcelis Technologies (NASDAQ:$ACLS) are two contenders. How do they stack up against each other, though? Let’s look at the stats of these two ... [Read]
      Imperva, Inc.
      Application Software

      Imperva, Inc. Expected to Report Upwards of $83.07 Million in Sales This Quarter

      Oct 24 Jen Jiang
      According to the Zacks Investment Research report, Equities analysts forecast that Imperva, Inc. (NYSE:$IMPV) will see sales of $83.07 million for the current quarter. Seven analysts have issued estimates for Imperva’s earnings. The lowest sales ... [Read]
      Impax Laboratories VS. SCYNEXIS
      Drug Manufacturers

      Head-to-Head: Impax Laboratories VS. SCYNEXIS

      Oct 24 Dylan Bernhardt
      Impax Laboratories (NASDAQ:$IPXL) and SCYNEXIS (NASDAQ:$SCYX) are both small-cap companies competing in the medical sector. So how do these two rivals stack up against each other? Let’s look at the numbers. Profitability Impax Laboratories has ... [Read]
      Anavex Life Sciences Corp.
      Health

      Anavex Life Sciences Corp.: Top Holders Statistics

      Oct 23 Jen Jiang
      Anavex Life Sciences Corp. (NASDAQ:$AVXL) reached 75.36% versus a 1-year low price of $2.76. On October 20th, the stock was last seen 3.64% higher, reaching at $4.84. At the most recent session, Anavex shares are ... [Read]
      SunPower Corporation's Rating
      Economy

      SunPower Corporation’s Rating Lowered by Zacks Investment Research

      Oct 23 Dylan Bernhardt
      In a report on Tuesday, Zacks Investment Research lowered their SunPower Corporation (NASDAQ:$SPWR) stock rating from ‘Buy’ to ‘Hold’. “SunPower is gradually shifting its revenue base from solar panel sales to the development of solar ... [Read]
      Biotechnology

      Zacks Investment Research Upgrades VBI Vaccines, Inc. to ‘Hold’

      Oct 20 Dylan Bernhardt
      A report on Tuesday from Zacks Investment Research upgraded VBI Vaccines (NASDAQ:$VBIV), Inc from a ‘Sell’ to a ‘Hold’ rating. VBI Vaccines is a biotechnology company that specializes in developing vaccines and antigens for issues ... [Read]
      Impax Laboratories a Buy
      Drug Manufacturers

      Is Impax Laboratories a Buy At $16?

      Oct 20 Dylan Bernhardt
      Impax Laboratories (NASDAQ:$IPXL) currently has a going rate of $20.75 per share. This could be a shaky proposition for some investors. However, there may be another way to get in on the drug manufacturer’s stock. ... [Read]

      Posts pagination

      « 1 2 3 4 … 6 »

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2026 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2026 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767